Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy

Fig. 3

The cumulative survival rates at different time points in the entire cohort (N = 1139; 216 in the non-antiviral group vs. 923 in the antiviral group) and propensity score matched cohort (N = 348; 174 in the non-antiviral group vs. 174 in the antiviral group). The entire cohort: a, 1 year, b, 2 year, c, 3 year, d, 5 year. The PS matching cohort: e, 1 year, f, 2 year, g, 3 year, h, 5 year

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us